MOUSE MONOCLONAL ANTIBODIES RAISED TO THE T-CELL LINE HSB-2 AND T-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (T-CLL) CELLS REACT WITH NORMAL HUMAN T AND B LYMPHOCYTES AND MONOCYTES
The prevent invention relates to two monoclonal antibodies which are broadly reactive with all normal human peripheral blood T and B lymphocytes and monocytes and to hybridoma cell lines which produce these monoclonal antibodies. These monoclonal antibodies are designated WM-66 and WM-63 and the res...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The prevent invention relates to two monoclonal antibodies which are broadly reactive with all normal human peripheral blood T and B lymphocytes and monocytes and to hybridoma cell lines which produce these monoclonal antibodies. These monoclonal antibodies are designated WM-66 and WM-63 and the respective hybridoma cell lines are designated F56-2D7 (ECAC 88101104) and F56-4D6 (ECACC 88101103). Both of these monoclonal antibodies react with a previously unrecognised human leucocyte differentiation antigen. The relative molecular mass of the antigen recognised by WM-66 is approximately 65 kilodaltons.
La présente invention se rapporte à deux anticorps monoclonaux qui réagissent largement avec tous les monocytes et les lymphocytes T et B normaux de sang périphérique de l'homme, ainsi qu'à des lignées cellulaires d'hybridomes produisant ces anticorps monoclonaux. Ces anticorps monoclonaux sont appelés WM-66 et WM-63 et les lignées cellulaires d'hybridomes respectives sont appelées F56-2D7 (ECAC 88101104) et F56-4D6 (ECACC 88101103). Ces anticorps monoclonaux réagissent tous les deux avec un antigène de différenciation de leucocytes humains auparavant non reconnu. La masse moléculaire relative de l'antigène appelé WM-66 est approximativement de 65 kilodaltons. |
---|